Patients with Primary Immunodeficiency Diseases (PIDD) are not only susceptible to infection, but they are also at risk for other, non-infectious, complications.  Some of these non-infectious complications can be life-threatening for the patient. This session is intended to discuss how to monitor for these complications, the pathophysiology behind these complications, and the impact new immune therapies have on management of patients with PIDD.

Host: Gerald Lee, MD, FACAAI, Experts: Carla Davis, MD, Vivian Hernandez-Trujillo, MD Disclosures

To download the mp3 file, right click on the player and select Save audio as.

Interested in claiming CME for this episode? Click here

Resources

Speaker Disclosures back to top

Gerald Lee, MD - No relevant financial relationships with ineligible companies to disclose

Carla Davis, MD
Consultant: Moonlight Therapeutics
Invesigator: DBV, Aimmune, Regeneron, Allakos

Vivian Hernandez-Trujillo, MD
Speaker: Takeda, Kovis
Advisory Board: Takeda, CSL Behring, Regeneron, DBV, US World Meds, Covis, Kaleo
Consultant: Kovi

This podcast series is supported by Pfizer.